24th January 2022
$2.8m MRFF boost for vital cancer immunotherapy research
Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant
Latest News
22 October 2020
Genomic treasure trove
Dr Mark Adams is uncovering potential new treatments and diagnostics as he delves into the human genome.
More about Genomic treasure trove 
14 October 2020
New medtech manufacturing capability
TRI launches its new state-of-the-art clinical cleanroom manufacturing and training facility, T3 Cleanrooms.
More about New medtech manufacturing capability 
15 September 2020
Research focus on rare lymphomas
Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at TRI.
More about Research focus on rare lymphomas
14 September 2020
Drug doesn't reduce heart disease in kidney patients
TRI researchers were part of a large study looking at a commonly prescribed drug for kidney patients.
More about Drug doesn't reduce heart disease in kidney patients
10 September 2020
Invention driving needle-free vaccine delivery
TRI unpacks the Vaxxas journey as their needle-free vaccine delivery product nears commercial reality.
More about Invention driving needle-free vaccine deliveryPages
Events
21 March 2022 9:30 AM – 6:00 PM
ASSC Genetics Summit 21 March 2022
The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022 Upcoming Events
Sorry, no results found
Please try again with less restrictive search criteria
